Intelligent Bio Solutions Inc.
INBS
$2.47
$0.041.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.01% | 18.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.01% | 18.29% | |||
| Cost of Revenue | 15.95% | 20.23% | |||
| Gross Profit | 0.22% | 16.47% | |||
| SG&A Expenses | 21.61% | 5.20% | |||
| Depreciation & Amortization | -0.76% | 3.02% | |||
| Other Operating Expenses | -48.52% | -127.92% | |||
| Total Operating Expenses | 27.67% | 14.19% | |||
| Operating Income | -34.75% | -12.78% | |||
| Income Before Tax | -36.51% | -6.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -36.51% | -6.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 42.03% | -23.33% | |||
| Net Income | -36.50% | -6.91% | |||
| EBIT | -34.75% | -12.78% | |||
| EBITDA | -25.39% | -23.07% | |||
| EPS Basic | 12.98% | 36.25% | |||
| Normalized Basic EPS | 12.92% | 35.67% | |||
| EPS Diluted | 12.98% | 36.25% | |||
| Normalized Diluted EPS | 12.92% | 35.67% | |||
| Average Basic Shares Outstanding | 56.86% | 67.70% | |||
| Average Diluted Shares Outstanding | 56.86% | 67.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||